Mon, 17 Nov
|Virtual Events
The FDA QMSR and the Key Elements of QSIT cGMP Inspection and Audits for Medical Device Manufacturers
Faculty: John E. Lincoln | November 17 - 18, 2025 | Time: 10 AM to 3 PM Global companies must meet US FDA 21 CFR 820 (The QSR) requirements in order to sell such devices in the US, no matter where they are manufactured.
Time & Location
17 Nov 2025, 10:00 am GMT-5 – 18 Nov 2025, 3:00 pm GMT-5
Virtual Events
About the event
Description
What are U.S. FDA cGMP requirements for the manufacture of medical devices for sale in the US? Discuss the key Quality System Regulation / Quality Management System requirements of 21 CFR 820, the Quality System Regulation. QSIT for FDA inspections. And anticipated changes to a QMSR.
This 2-day seminar will examine the 14 key elements of the Medical Device cGMPs, 21 CFR 820, the Quality System Regulation, the 7 key elements, and the defining 4 elements, as defined and evaluated by the FDA's QSIT. Product development and manufacturing ("realization") and its compliance and documentation. Design Control, the Device History File, the Device Master Record and the Device History Record are defined. Corrective and Preventive Action (CAPA) requirements and key components. Production and Process Control (P&PC) expectations. Verification and Validation, including software - Why and How? Risk management under ISO 14971, a major component of the proposed QMSR, will also…
Register
Tickets
From $900.00 to $4,400.00
$900.00
+$22.50 ticket service fee
$1,700.00
+$42.50 ticket service fee
$2,400.00
+$60.00 ticket service fee
Total
$0.00